The use of these drugs produces a stimulant-like effect and carries much the same risk as stimulant drugs
Key areas of investigation include modulation of the nitric oxide (NO) system through interaction with NOS isoforms, upregulation of growth factor receptors (including VEGFR2 and EGF receptor systems), and engagement of the FAK-paxillin signaling cascade associated with cell migration and adhesion
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test analyzes genetic variants in GLP1R, GIPR, FTO, and MC4R pathways that may help provide context for individual metabolic predispositions and peptide receptor function
By potentially downregulating TGF-1, AHK-Cu may alter these cellular processes, possibly affecting cell growth and the immune response at a cellular level
However, clinical rigor dictates vigilance: the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency has flagged a possible rare risk of non-arteritic anterior ischemic optic neuropathy, a form of sudden blindness, associated with the use of these drugs
